Randomized Control Trial Testing the Effectiveness of Implemented Depression Prevention in High-risk Adolescents
Overview
Authors
Affiliations
Background: Adolescent depression is a global mental health concern. Identification and effective prevention in an early stage are necessary. The present randomized, controlled trial aimed to examine the effectiveness of Cognitive Behavioral Therapy (CBT)-based depression prevention in adolescents with elevated depressive symptoms. This prevention approach is implemented in school communities, which allows to examine effects under real-life circumstances.
Methods: A total of 5222 adolescents were screened for elevated depressive symptoms in the second grade of secondary schools; 130 adolescents aged between 12 and 16 years old (M = 13.59; SD = 0.68; 63.8% girls) were randomly assigned to the experimental (OVK 2.0) or control condition (psycho-education). Self- and parent-reported depressive symptoms were assessed at pretest and post intervention, as well as 6- and 12-months follow-up. Clinical assessment of depression was assessed at pretest and 6-months follow-up.
Results: Intent-to-treat analyses revealed that the decrease in adolescent-rated depressive symptoms was significantly larger in the intervention condition than in the control condition. There was no significant difference in decrease of parent-rated depressive symptoms between both conditions.
Conclusions: Based on the findings, we recommend the implementation of screening and prevention in schools, according the basics of this study design. Since this is a new step forward, we discuss the clinical impact and challenges, as well possibilities for future research.
Trial Registration: The study is registered in the Dutch Trial Register for RCT's ( NTR5725 ). Date registered: 11 March 2016.
Willems L, Rasing S, Heijs D, Vermulst A, Huvenaars M, Onrust S BMC Public Health. 2024; 24(1):2118.
PMID: 39103796 PMC: 11301861. DOI: 10.1186/s12889-024-19666-5.
Jenniskens K, Rasing S, Popma A, Creemers D, Ghalit C, van Vuuren L Front Public Health. 2024; 12:1386031.
PMID: 38799678 PMC: 11122015. DOI: 10.3389/fpubh.2024.1386031.
Bjornstad G, Sonthalia S, Rouse B, Freeman L, Hessami N, Hickman Dunne J Campbell Syst Rev. 2024; 20(1):e1376.
PMID: 38188230 PMC: 10771715. DOI: 10.1002/cl2.1376.
Braam M, Rasing S, Heijs D, Lokkerbol J, Bergen D, Creemers D BMC Public Health. 2023; 23(1):884.
PMID: 37173740 PMC: 10176867. DOI: 10.1186/s12889-023-15705-9.
OShields J, Graves B, Mowbray O Brain Behav Immun Health. 2023; 29:100611.
PMID: 36937648 PMC: 10017358. DOI: 10.1016/j.bbih.2023.100611.